查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1352871

全球基因组学人工智慧市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、成长、趋势和预测

Global Artificial Intelligence in Genomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 335 Pages | 商品交期: 最快1-2个工作天内

价格

全球基因组市场对人工智慧的需求预计将从 2022 年的 11.3 亿美元增至 2030 年的近 112.2 亿美元，2023-2030 年研究期间复合年增长率为 33.3%。

基因组学中的人工智慧涉及在医疗保健领域利用机器学习来诊断和理解遗传性疾病。基因组学中的人工智慧可以帮助医疗保健专业人员更好地了解癌症等致命疾病以及患者的几种罕见和退化性疾病。人工智慧有助于建立基因组数据，这比透过人类干预更快解释疾病有很大帮助。它可以更快地分析遗传物质的结构、功能和发育。

市场动态：

基因组学市场中的人工智慧在预测期内显示出令人满意的成长率。基因组学在个人化医疗中的作用将有助于该市场的成长，因为人工智慧的应用有助于更快地製造药品。公共和私营部门组织减少药物开发时间和成本以及增加对基因组学人工智慧投资的必要性促进了市场的成长。此外，日益增长的精准医疗製造是另一个市场成长动力，重点在于遗传、生活方式和环境在人类疾病中的作用。同样，在开药之前使用患者的基因图谱来发现患者个体需求的个人化医疗方法可能会影响基因组学市场中人工智慧的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球基因组学人工智慧市场的各个细分市场进行了包容性评估。基因组学产业人工智慧的成长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲基因组学市场人工智慧当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。基因组学市场人工智慧的主要参与者包括IBM（美国）、微软（美国）、NVIDIA公司（美国）、Deep Genomics（加拿大）、BenevolentAI（英国）、Fabric Genomics Inc.（美国）、Verge Genomics（美国） )、Freenome Holdings, Inc.（美国）、MolecularMatch Inc.（美国）、Cambridge Cancer Genomics（英国）、SOPHiA GENETICS（美国）、Data4Cure Inc.（美国）、PrecisionLife Ltd（英国）、Genoox Ltd.（美国） 、Lifebit（英国）、Diploid（比利时）、FDNA Inc.（美国）、DNAnexus Inc.（美国）、Empiric Logic（爱尔兰）和Engine Biosciences Pte.有限公司（美国）。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：基因组学中的人工智慧 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品提供的市场吸引力分析
    • 按技术分類的市场吸引力分析
    • 按功能分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

5 COVID-19 爆发的影响分析

  • Covid-19 爆发的影响分析
    • 对生产的直接影响
    • 供应炼和市场颠覆
    • 对公司和金融市场的财务影响
  • 按生产、进口、出口和需求分類的 COVID-19 影响分析
  • 市场：COVID-19 前 V/S 后
  • 冠状病毒 (COVID-19) 疫情的预期影响
  • COVID-19：微观和宏观因素分析

第 6 章：全球人工智慧基因组市场分析：透过提供

  • 按产品分类概述
  • 历史和预测数据
  • 按产品分析
  • 软体
  • 服务

第 7 章：全球人工智慧基因组市场分析：按技术分类

  • 依技术概述
  • 历史和预测数据
  • 依技术分析
  • 机器学习
  • 深度学习
  • 监督学习
  • 强化学习
  • 无监督学习
  • 其他机器学习技术
  • 其他技术

第 8 章：全球人工智慧基因组市场分析：按功能分类

  • 按功能概述
  • 历史和预测数据
  • 按功能分析
  • 基因组定序
  • 基因编辑
  • 临床工作流程
  • 预测基因检测与预防医学

第 9 章：全球人工智慧在基因组学市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 诊断
  • 药物发现与开发
  • 精准医疗
  • 农业与动物研究
  • 其他应用

第 10 章：全球人工智慧基因组市场分析：按最终用户分类

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 製药与生物技术公司
  • 医疗保健机构
  • 研究中心、学术机构
  • 政府机构
  • 其他最终用户

第 11 章：全球人工智慧基因组市场分析：按地理位置

  • 顶尖公司股票分析
  • 介绍
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 12 章：基因组公司人工智慧的竞争格局

  • 基因组市场竞争中的人工智慧
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 13 章：公司简介

  • 公司股份分析
  • 市场集中度
  • IBM (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Microsoft (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • NVIDIA Corporation (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Deep Genomics (Canada)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BenevolentAI (UK)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Fabric Genomics Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Verge Genomics (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Freenome Holdings Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • MolecularMatch Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Cambridge Cancer Genomics (UK)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • SOPHiA GENETICS (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Data4Cure Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • PrecisionLife Ltd (UK)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Genoox Ltd. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Lifebit (UK)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Diploid (Belgium)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • FDNA Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • DNAnexus Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Empiric Logic (Ireland)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Engine Biosciences Pte. Ltd. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR11218912

The global demand for Artificial Intelligence in Genomics Market is presumed to reach the market size of nearly USD 11.22 BN by 2030 from USD 1.13 BN in 2022 with a CAGR of 33.3% under the study period 2023 - 2030.

Artificial Intelligence in Genomics involves the utilization of machine learning in the field of healthcare to diagnose and understand genetic disorders. AI in genomics helps healthcare professionals to understand better deadly diseases like cancer and several rare and degenerative conditions in patients. AI helps in the structuring of genomic data, and this helps a great deal in interpreting diseases faster than doing it through human intervention. It enables a faster analysis of the structure, functioning and development of the genetic materials.

MARKET DYNAMICS:

Artificial Intelligence in Genomics market shows a satisfactory growth rate during the projection period. The role of genomics in personalized medicine will help the growth of this market as the application of AI helps in the faster manufacturing of medicines. The necessity to reduce time and cost in drug development and increase investments made in AI in genomics by the public and private sector organizations have contributed to the market's growth. Moreover, the growing manufacturing of precision medicine, which focuses on the role of genetics, lifestyle, and environment in the diseases in humans, is another market driver of growth. Similarly, the personalized medicine method that uses patients' genetic profiles to discover the individual patient requirements before prescribing medicine is likely to influence the growth of the AI in genomics market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of artificial intelligence in genomics. The growth and trends of artificial intelligence in genomics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the artificial intelligence in genomics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Offering

  • Software
  • Services

By Technology

  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Machine Learning Technologies
  • Other Technologies

By Functionality

  • Genome Sequencing
  • Gene Editing
  • Clinical Workflows
  • Predictive Genetic Testing & Preventive Medicine

By Application

  • Diagnostics
  • Drug Discovery & Development
  • Precision Medicine
  • Agriculture & Animal Research
  • Other Applications

By End User

  • Pharmaceutical & Biotech Companies
  • Healthcare Providers
  • Research Centers, Academic Institutes
  • Government Organizations
  • Other End Users

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Artificial Intelligence in Genomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the artificial intelligence in genomics market include IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK), Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), and Engine Biosciences Pte. Ltd. (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ARTIFICIAL INTELLIGENCE IN GENOMICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Offering
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Functionality
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End User
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY OFFERING

  • 6.1 Overview by Offering
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Offering
  • 6.4 Software Historic and Forecast Sales by Regions
  • 6.5 Services Historic and Forecast Sales by Regions

7 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY TECHNOLOGY

  • 7.1 Overview by Technology
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Technology
  • 7.4 Machine Learning Historic and Forecast Sales by Regions
  • 7.5 Deep Learning Historic and Forecast Sales by Regions
  • 7.6 Supervised Learning Historic and Forecast Sales by Regions
  • 7.7 Reinforcement Learning Historic and Forecast Sales by Regions
  • 7.8 Unsupervised Learning Historic and Forecast Sales by Regions
  • 7.9 Other Machine Learning Technologies Historic and Forecast Sales by Regions
  • 7.10. Other Technologies Historic and Forecast Sales by Regions

8 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY FUNCTIONALITY

  • 8.1 Overview by Functionality
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Functionality
  • 8.4 Genome Sequencing Historic and Forecast Sales by Regions
  • 8.5 Gene Editing Historic and Forecast Sales by Regions
  • 8.6 Clinical Workflows Historic and Forecast Sales by Regions
  • 8.7 Predictive Genetic Testing & Preventive Medicine Historic and Forecast Sales by Regions

9 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Diagnostics Historic and Forecast Sales by Regions
  • 9.5 Drug Discovery & Development Historic and Forecast Sales by Regions
  • 9.6 Precision Medicine Historic and Forecast Sales by Regions
  • 9.7 Agriculture & Animal Research Historic and Forecast Sales by Regions
  • 9.8 Other Applications Historic and Forecast Sales by Regions

10 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY END USER

  • 10.1 Overview by End User
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End User
  • 10.4 Pharmaceutical & Biotech Companies Historic and Forecast Sales by Regions
  • 10.5 Healthcare Providers Historic and Forecast Sales by Regions
  • 10.6 Research Centers, Academic Institutes Historic and Forecast Sales by Regions
  • 10.7 Government Organizations Historic and Forecast Sales by Regions
  • 10.8 Other End Users Historic and Forecast Sales by Regions

11 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE ARTIFICIAL INTELLIGENCE IN GENOMICS COMPANIES

  • 12.1. Artificial Intelligence In Genomics Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF ARTIFICIAL INTELLIGENCE IN GENOMICS INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. IBM (US)
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Microsoft (US)
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. NVIDIA Corporation (US)
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Deep Genomics (Canada)
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. BenevolentAI (UK)
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Fabric Genomics Inc. (US)
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Verge Genomics (US)
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Freenome Holdings Inc. (US)
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. MolecularMatch Inc. (US)
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Cambridge Cancer Genomics (UK)
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. SOPHiA GENETICS (US)
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. Data4Cure Inc. (US)
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. PrecisionLife Ltd (UK)
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments
  • 13.16. Genoox Ltd. (US)
    • 13.16.1. Company Overview
    • 13.16.2. Company Revenue
    • 13.16.3. Products
    • 13.16.4. Recent Developments
  • 13.17. Lifebit (UK)
    • 13.17.1. Company Overview
    • 13.17.2. Company Revenue
    • 13.17.3. Products
    • 13.17.4. Recent Developments
  • 13.18. Diploid (Belgium)
    • 13.18.1. Company Overview
    • 13.18.2. Company Revenue
    • 13.18.3. Products
    • 13.18.4. Recent Developments
  • 13.19. FDNA Inc. (US)
    • 13.19.1. Company Overview
    • 13.19.2. Company Revenue
    • 13.19.3. Products
    • 13.19.4. Recent Developments
  • 13.20. DNAnexus Inc. (US)
    • 13.20.1. Company Overview
    • 13.20.2. Company Revenue
    • 13.20.3. Products
    • 13.20.4. Recent Developments
  • 13.21. Empiric Logic (Ireland)
    • 13.21.1. Company Overview
    • 13.21.2. Company Revenue
    • 13.21.3. Products
    • 13.21.4. Recent Developments
  • 13.22. Engine Biosciences Pte. Ltd. (US)
    • 13.22.1. Company Overview
    • 13.22.2. Company Revenue
    • 13.22.3. Products
    • 13.22.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Offering (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Technology (USD MN)
  • Machine Learning Market Sales by Geography (USD MN)
  • Deep Learning Market Sales by Geography (USD MN)
  • Supervised Learning Market Sales by Geography (USD MN)
  • Reinforcement Learning Market Sales by Geography (USD MN)
  • Unsupervised Learning Market Sales by Geography (USD MN)
  • Other Machine Learning Technologies Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Analysis by Functionality (USD MN)
  • Genome Sequencing Market Sales by Geography (USD MN)
  • Gene Editing Market Sales by Geography (USD MN)
  • Clinical Workflows Market Sales by Geography (USD MN)
  • Predictive Genetic Testing & Preventive Medicine Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Diagnostics Market Sales by Geography (USD MN)
  • Drug Discovery & Development Market Sales by Geography (USD MN)
  • Precision Medicine Market Sales by Geography (USD MN)
  • Agriculture & Animal Research Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Pharmaceutical & Biotech Companies Market Sales by Geography (USD MN)
  • Healthcare Providers Market Sales by Geography (USD MN)
  • Research Centers, Academic Institutes Market Sales by Geography (USD MN)
  • Government Organizations Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Artificial Intelligence In Genomics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Artificial Intelligence In Genomics Report
  • Market Research Process
  • Market Research Methodology
  • Global Artificial Intelligence In Genomics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Offering
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Functionality
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Offering (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Machine Learning Market Sales by Geography (USD MN)
  • Deep Learning Market Sales by Geography (USD MN)
  • Supervised Learning Market Sales by Geography (USD MN)
  • Reinforcement Learning Market Sales by Geography (USD MN)
  • Unsupervised Learning Market Sales by Geography (USD MN)
  • Other Machine Learning Technologies Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Global Market Analysis by Functionality (USD MN)
  • Genome Sequencing Market Sales by Geography (USD MN)
  • Gene Editing Market Sales by Geography (USD MN)
  • Clinical Workflows Market Sales by Geography (USD MN)
  • Predictive Genetic Testing & Preventive Medicine Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Diagnostics Market Sales by Geography (USD MN)
  • Drug Discovery & Development Market Sales by Geography (USD MN)
  • Precision Medicine Market Sales by Geography (USD MN)
  • Agriculture & Animal Research Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Pharmaceutical & Biotech Companies Market Sales by Geography (USD MN)
  • Healthcare Providers Market Sales by Geography (USD MN)
  • Research Centers, Academic Institutes Market Sales by Geography (USD MN)
  • Government Organizations Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.